Second Meeting of French Society of Pharmacology, Nancy, 23-25 March 1998: Potential problems when switching from one excipient to another in drug formulation;L'interchangeabilite des excipients en formulation et ses consequences eventuelles

Therapie

Volumn 54, Issue 1, 1999, Pages 5-10

  Maincent, P ^a  

^a CM UJ   (France)

Author keywords

Bioavailability; Excipients; Pharmacopoeia; Similarity; Switchability

Indexed keywords

EXCIPIENT; MICROCRYSTALLINE CELLULOSE; PREDNISONE; UMINAC MG 100; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; MEDICAL LITERATURE; PRIORITY JOURNAL; TABLET MANUFACTURE; ARTICLE; BIOAVAILABILITY; COMPARATIVE STUDY; DRUG DOSAGE FORM; HUMAN; STRUCTURE ACTIVITY RELATION;

BIOLOGICAL AVAILABILITY; DOSAGE FORMS; EXCIPIENTS; HUMANS; PHARMACOPOEIAS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032604354     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Wade A, Weller PJ. Handbook of Excipients. Second edn. Washington DC: American Pharmaceutical Association, 1994.
2. Landin M, Martinez-Pacheco R, Gomez-Amoza JL et al. Effect of country of origin on the properties of microcrystalline cellulose. Int J Pharm 1993; 91: 123-131.
3. Landin M, Martinez-Pacheco R, Gomez-Amoza JL et al. Effect of batch variation and source of pulp on the properties of microcrystalline cellulose. Int J Pharm 1993; 91: 133-141.
4. Landin M, Martinez-Pacheco R, Gomez-Amoza JL et al. Influence of microcrystalline cellulose source and batch variation on the tableting behaviour and stability of prednisone formulations. Int J Pharm 1993; 91: 143-149.
5. Chowhan ZT. Excipients and their functionality in drug product development. Pharm Technol Europe 1993; 5: 33-46.